石灰沈着症治療の世界市場レポート 2025年

石灰沈着症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.5％で28億4,000万米ドルに成長します。予測期間における成長の背景には、ヘルスケア支出の増加、コラボレーションやパートナーシップの増加、個別化医療への注力、規制当局のサポートと迅速な承認、患者中心のヘルスケアアプローチがあります。予測期間の主な動向には、新たな治療法、診断の進歩、研究開発の増加、共同イニシアティブ、患者中心のアプローチ、規制状況のダイナミクスなどが含まれます。

腎臓病有病率の増加が予想され、石灰沈着症治療市場の成長を牽引します。腎臓疾患は、老廃物や余分な水分をろ過する重要な機能に影響を与え、カルシウムやリン酸の代謝を阻害し、石灰沈着症のリスクを高める。2023年の英国における慢性腎臓病の罹患者数は719万人と推定され、人口の10％以上を占め、2033年には761万人に達すると予想されることから、腎臓病の有病率の増加が石灰沈着症治療市場の主要な促進要因となります。

進行中の臨床試験の拡大が石灰沈着症治療市場をさらに押し上げると予想されます。臨床試験は、潜在的な治療法の安全性と有効性を評価する上で極めて重要な役割を果たし、治療アプローチの改善に役立つ貴重なエビデンスとなります。登録試験数は世界全体で2022年の437,523から2023年には468,457に増加しており、進行中の臨床試験は石灰沈着症の医学的理解と治療に不可欠な洞察と進歩をもたらし、市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界石灰沈着症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の石灰沈着症治療市場：成長率分析
• 世界の石灰沈着症治療市場の実績：規模と成長, 2019-2024
• 世界の石灰沈着症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界石灰沈着症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の石灰沈着症治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 高圧酸素療法
• その他のタイプ
• 世界の石灰沈着症治療市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• イメージング
• 血液検査
• 深部皮膚生検
• 世界の石灰沈着症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 医療研究センター
• 学術機関
• 世界の石灰沈着症治療市場、医薬品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• チオ硫酸ナトリウム
• ビスフォスフォネート
• シナカルセト
• 副甲状腺ホルモン
• 高圧酸素療法
• 世界の石灰沈着症治療市場高圧酸素療法の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単場所高圧酸素療法
• 多場所高圧酸素療法
• 世界の石灰沈着症治療市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 透析
• 創傷ケアと管理
• 外科的介入

第7章 地域別・国別分析

• 世界の石灰沈着症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の石灰沈着症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 石灰沈着症治療市場：競合情勢
• 石灰沈着症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca Plc
• Sanofi SA
• 3M Company
• GlaxoSmithKline Plc
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim
• Novo Nordisk
• Viatris（Mylan N.V.）
• Regeneron Pharmaceuticals Inc.
• Smith And Nephew Plc.
• Incyte Corporation
• ConvaTec Inc.
• Vifor Pharma Group
• BSN Medical GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 石灰沈着症治療市場2029：新たな機会を提供する国
• 石灰沈着症治療市場2029：新たな機会を提供するセグメント
• 石灰沈着症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare and severe medical condition characterized by the deposition of calcium in small blood vessels and tissues. It primarily affects individuals with kidney disease, especially those with end-stage renal disease (ESRD). The treatment approach involves pain management and nutritional support therapies to address symptoms such as painful and non-healing skin ulcers, tissue necrosis, and potential complications such as sepsis, which can pose life-threatening risks.

The main types of calciphylaxis treatment include medication, hyperbaric oxygen therapy, and other interventions. Medication involves the use of pharmaceutical drugs to manage symptoms and underlying causes. Medications such as sodium thiosulfate, opioids, or non-opioid drugs may be employed to treat or prevent infections, manage pain, and address aspects associated with calciphylaxis. Diagnosis is typically carried out through imaging, blood tests, and deep skin biopsies performed by end users such as hospitals, clinics, medical research centers, and academic institutes.

The calciphylaxis treatment market research report is one of a series of new reports from The Business Research Company that provides calciphylaxis treatment market statistics, including calciphylaxis treatment industry global market size, regional shares, competitors with an calciphylaxis treatment market share, detailed calciphylaxis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the calciphylaxis treatment industry. This calciphylaxis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The calciphylaxis treatment market size has grown rapidly in recent years. It will grow from $1.86 billion in 2024 to $2.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing incidence of calciphylaxis, rising awareness among healthcare professionals, expanding healthcare infrastructure, clinical research and drug development.

The calciphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $2.84 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising healthcare expenditure, increasing collaboration and partnerships, focus on personalized medicine, regulatory support and expedited approvals, patient-centric healthcare approaches. Major trends in the forecast period include emerging therapeutic modalities, diagnostic advancements, increased research and development, collaborative initiatives, patient-centric approaches, regulatory landscape dynamics.

The anticipated rise in the prevalence of kidney diseases is set to drive the growth of the calciphylaxis treatment market. Kidney diseases, affecting the vital function of filtering waste products and excess fluids, disrupt calcium and phosphate metabolism, increasing the risk of calciphylaxis. With an estimated 7.19 million people affected by chronic kidney disease in the UK in 2023, representing over 10% of the population and expected to reach 7.61 million by 2033, the growing prevalence of kidney diseases will be a key driver for the calciphylaxis treatment market.

The expansion of ongoing clinical trials is expected to further boost the calciphylaxis treatment market. Clinical trials play a pivotal role in assessing the safety and efficacy of potential treatments, contributing valuable evidence for improved therapeutic approaches. With the number of registered studies increasing from 437,523 in 2022 to 468,457 in 2023 globally, the ongoing clinical trials provide essential insights and advancements in the medical understanding and treatment of calciphylaxis, contributing to the market's growth.

Leading companies in the calciphylaxis treatment market are focusing on developing advanced diagnostic techniques and health evaluation services to enhance profitability. By introducing comprehensive in-home kidney health evaluations, companies such as Signify Health, Inc. aim to provide convenient and proactive monitoring solutions for kidney health. Such initiatives, including urinalysis and estimated glomerular filtration rate assessments, prove valuable in early detection and management of chronic kidney health issues, including conditions such as calciphylaxis.

In January 2024, Merck KGaA, a Germany-based science and technology company providing calciphylaxis treatment, partnered with Inspirna Inc. Through this partnership, Merck KGaA expanded its colorectal cancer portfolio via a licensing agreement for the drug ompenaclid (RGX-202). This first-in-class oral inhibitor targets the creatine transport channel SLC6A8 and is currently in Phase II development for advanced RAS-mutated colorectal cancer (mCRC). Inspirna Inc. is a U.S.-based clinical-stage biopharmaceutical company.

Major companies operating in the calciphylaxis treatment market report are Pfizer Inc., Merck And Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, 3M Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Novo Nordisk, Viatris (Mylan N.V.), Regeneron Pharmaceuticals Inc., Smith And Nephew Plc., Incyte Corporation, ConvaTec Inc., Vifor Pharma Group, BSN Medical GmbH, Panion And BF Biotech Inc., Inozyme Pharma Inc., Sanifit Therapeutics S.A, Hope Pharmaceuticals, Menlo Therapeutics

North America was the largest region in the calciphylaxis treatment market in 2024 Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calciphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the calciphylaxis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The calciphylaxis treatment market consists of revenues earned by entities by providing diagnostic services such as infrared thermography, electrolyte and mineral analysis, and measuring serum parathyroid hormone (PTH) levels to diagnose and assess the severity of calciphylaxis in patients. The market value includes the value of related goods sold by the service provider or included within the service offering. The calciphylaxis treatment market also includes sales of intensive wound care, clot-dissolving therapy, and vitamin K therapy, which are comprehensive treatment approaches for managing calciphylaxis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Calciphylaxis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on calciphylaxis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for calciphylaxis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The calciphylaxis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Medication; Hyperbaric Oxygen Therapy; Other Types
• 2) By Diagnosis: Imaging; Blood Tests; Deep Skin Biopsies
• 3) By End User: Hospitals; Clinics; Medical Research Centers; Academic Institutes
• Subsegments:
• 1) By Medication: Sodium Thiosulfate; Bisphosphonates; Cinacalcet; Parathyroid Hormone; Hyperbaric Oxygen Therapy
• 2) By Hyperbaric Oxygen Therapy: Monoplace Hyperbaric Oxygen Therapy; Multiplace Hyperbaric Oxygen Therapy
• 3) By Other Types: Dialysis; Wound Care And Management; Surgical Interventions
• Companies Mentioned: Pfizer Inc.; Merck And Co. Inc.; AbbVie Inc; Novartis AG; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Calciphylaxis Treatment Market Characteristics

3. Calciphylaxis Treatment Market Trends And Strategies

4. Calciphylaxis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Calciphylaxis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Calciphylaxis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Calciphylaxis Treatment Market Growth Rate Analysis
• 5.4. Global Calciphylaxis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Calciphylaxis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Calciphylaxis Treatment Total Addressable Market (TAM)

6. Calciphylaxis Treatment Market Segmentation

• 6.1. Global Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Hyperbaric Oxygen Therapy
• Other Types
• 6.2. Global Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging
• Blood Tests
• Deep Skin Biopsies
• 6.3. Global Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Medical Research Centers
• Academic Institutes
• 6.4. Global Calciphylaxis Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sodium Thiosulfate
• Bisphosphonates
• Cinacalcet
• Parathyroid Hormone
• Hyperbaric Oxygen Therapy
• 6.5. Global Calciphylaxis Treatment Market, Sub-Segmentation Of Hyperbaric Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoplace Hyperbaric Oxygen Therapy
• Multiplace Hyperbaric Oxygen Therapy
• 6.6. Global Calciphylaxis Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dialysis
• Wound Care And Management
• Surgical Interventions

7. Calciphylaxis Treatment Market Regional And Country Analysis

• 7.1. Global Calciphylaxis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Calciphylaxis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Calciphylaxis Treatment Market

• 8.1. Asia-Pacific Calciphylaxis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Calciphylaxis Treatment Market

• 9.1. China Calciphylaxis Treatment Market Overview
• 9.2. China Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Calciphylaxis Treatment Market

• 10.1. India Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Calciphylaxis Treatment Market

• 11.1. Japan Calciphylaxis Treatment Market Overview
• 11.2. Japan Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Calciphylaxis Treatment Market

• 12.1. Australia Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Calciphylaxis Treatment Market

• 13.1. Indonesia Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Calciphylaxis Treatment Market

• 14.1. South Korea Calciphylaxis Treatment Market Overview
• 14.2. South Korea Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Calciphylaxis Treatment Market

• 15.1. Western Europe Calciphylaxis Treatment Market Overview
• 15.2. Western Europe Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Calciphylaxis Treatment Market

• 16.1. UK Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Calciphylaxis Treatment Market

• 17.1. Germany Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Calciphylaxis Treatment Market

• 18.1. France Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Calciphylaxis Treatment Market

• 19.1. Italy Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Calciphylaxis Treatment Market

• 20.1. Spain Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Calciphylaxis Treatment Market

• 21.1. Eastern Europe Calciphylaxis Treatment Market Overview
• 21.2. Eastern Europe Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Calciphylaxis Treatment Market

• 22.1. Russia Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Calciphylaxis Treatment Market

• 23.1. North America Calciphylaxis Treatment Market Overview
• 23.2. North America Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Calciphylaxis Treatment Market

• 24.1. USA Calciphylaxis Treatment Market Overview
• 24.2. USA Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Calciphylaxis Treatment Market

• 25.1. Canada Calciphylaxis Treatment Market Overview
• 25.2. Canada Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Calciphylaxis Treatment Market

• 26.1. South America Calciphylaxis Treatment Market Overview
• 26.2. South America Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Calciphylaxis Treatment Market

• 27.1. Brazil Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Calciphylaxis Treatment Market

• 28.1. Middle East Calciphylaxis Treatment Market Overview
• 28.2. Middle East Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Calciphylaxis Treatment Market

• 29.1. Africa Calciphylaxis Treatment Market Overview
• 29.2. Africa Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Calciphylaxis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Calciphylaxis Treatment Market Competitive Landscape
• 30.2. Calciphylaxis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Calciphylaxis Treatment Market Other Major And Innovative Companies

• 31.1. AstraZeneca Plc
• 31.2. Sanofi SA
• 31.3. 3M Company
• 31.4. GlaxoSmithKline Plc
• 31.5. Eli Lilly and Company
• 31.6. Amgen Inc.
• 31.7. Boehringer Ingelheim
• 31.8. Novo Nordisk
• 31.9. Viatris (Mylan N.V.)
• 31.10. Regeneron Pharmaceuticals Inc.
• 31.11. Smith And Nephew Plc.
• 31.12. Incyte Corporation
• 31.13. ConvaTec Inc.
• 31.14. Vifor Pharma Group
• 31.15. BSN Medical GmbH

32. Global Calciphylaxis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Calciphylaxis Treatment Market

34. Recent Developments In The Calciphylaxis Treatment Market

35. Calciphylaxis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Calciphylaxis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Calciphylaxis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Calciphylaxis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer